Contact
Please use this form to send email to PR contact of this press release:
MorphoSys and Galapagos Start First-In-Patient Dosing of IL-17C Antibody MOR106 in Atopic Dermatitis
TO:
Please use this form to send email to PR contact of this press release:
MorphoSys and Galapagos Start First-In-Patient Dosing of IL-17C Antibody MOR106 in Atopic Dermatitis
TO: